Statistics for Dialkynylimidazoles as irreversible MAPK inhibitors, kinase docking site probes, and anti-cancer agents

Total visits

views
Dialkynylimidazoles as irreversible MAPK inhibitors, kinase docking site probes, and anti-cancer agents 364

Total visits per month

views
October 2023 0
November 2023 0
December 2023 0
January 2024 1
February 2024 0
March 2024 0
April 2024 0

File Visits

views
LI-DISSERTATION.pdf(legacy) 1201
LI-DISSERTATION.pdf 286

Top country views

views
United States 249
China 52
France 34
South Korea 24
Germany 22
United Kingdom 16
India 12
Belarus 6
Netherlands 5
Finland 4
Sweden 4
Canada 3
Singapore 2
Austria 1
Australia 1
Switzerland 1
Czechia 1
Hong Kong SAR China 1
Iran 1
Italy 1
Malaysia 1
Romania 1
Russia 1
Saudi Arabia 1
Thailand 1
Taiwan 1

Top city views

views
Cleveland 31
Beijing 27
Miami 24
Beverly Hills 22
Palo Alto 16
Dallas 15
Sunnyvale 10
Ashburn 9
Tianjin 8
Tokyo 8
Houston 5
Zhengzhou 5
Fort Lauderdale 4
Bengaluru 3
New York 3
Bangalore 2
Bhubaneswar 2
Boston 2
Changsha 2
Chapel Hill 2
Cincinnati 2
Council Bluffs 2
Laval 2
Midvale 2
Milton Keynes 2
Sacramento 2
Shanghai 2
Winston Salem 2
Austin 1
Busan 1
Canterbury 1
Chennai 1
Chungnam 1
Cugnasco 1
Des Moines 1
Frankfurt am Main 1
Guangzhou 1
Iselin 1
Kannur 1
Kolkata 1
Kyle 1
Mcallen 1
Mumbai 1
Nanaimo 1
Nanchang 1
New Hyde Park 1
Nuremberg 1
Olalla 1
Petaling Jaya 1
Pittsburgh 1
Rayong 1
Riyadh 1
Rock Hill 1
San Bruno 1
San Mateo 1
Seoul 1
Shenzhen 1
Singapore 1
Solna 1
Sydney 1
Taichung 1
Tehran 1
Tiruppur 1
Woodbridge 1